UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 Commission File Number: 001-37752 CHROMADEX CORPORATION (Exact Name of Registrant as Specified in its Charter) | --- | --- | --- | |----------------------------------------------------------------------------------|----------------------------|---------------------------------------------- ...

ChromaDex Corporation (NASDAQ:CDXC) Q2 2022 Results Conference Call August 10, 2022 4:30 AM ET Company Participants Heather Van Blarcom - Senior Vice President of Legal and Corporate Secretary Robert Fried - Chief Executive Officer Kevin Farr - Chief Financial Officer Brianna Gerber - Vice President of Finance and Investor Relations Conference Call Participants Brian Nagel - Oppenheimer Mitchell Pinheiro - Sturdivant Raghuram Selvaraju - H.C. Wainwright Sean McGowan - ROTH Capital Jeffrey Cohen - Ladenburg ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 Commission File Number: 001-37752 CHROMADEX CORPORATION (Exact Name of Registrant as Specified in its Charter) | --- | --- | --- | |----------------------------------------------------------------------------------|----------------------------|--------------------------------------------------- ...

| --- | --- | |--------------------------|-------| | | | | ChromaDex | | | | | | | | | | | | Earnings Conference Call | | | | | | First Quarter 2022 | | Rob Fried Chief Executive Officer Frank Jaksch Co-Founder / Executive Chairman Kevin Farr Chief Financial Officer Nasdaq: CDXC | May 2022 SAFE HARBOR STATEMENT 2 This presentation and other written or oral statements made from time to time by representatives of ChromaDex contain "forward-looking statements" within the meaning of Section 27A of the Securitie ...

ChromaDex Corporation (NASDAQ:CDXC) Q1 2022 Earnings Conference Call May 12, 2022 4:30 PM ET Company Participants Rob Fried – Chief Executive Officer Kevin Farr – Chief Financial Officer Brianna Gerber – Vice President of Finance, Investor Relation Frank Jaksch – Co-Founder and Executive Chairman Conference Call Participants Brian W. Nagel – Oppenheimer & Co. Mitchell Pinheiro – Sturdivant & Co. Sean McGowan – ROTH Capital Partners Bill Dezellem – Tieton Capital Management Operator Ladies and gentlemen, tha ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 Commission File Number: 001-37752 CHROMADEX CORPORATION (Exact Name of Registrant as Specified in its Charter) | --- | --- | --- | |----------------------------------------------------------------------------------|----------------------------|-------------------------------------------------- ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the transition period from to . Commission file number 001-37752 CHROMADEX CORPORATION (Exact name of Registrant as specified in its Charter) Delaware 26-2940963 (State or other jurisdiction of incorp ...

ChromaDex Corporation (NASDAQ:CDXC) Q4 2021 Earnings Conference Call March 9, 2022 4:30 PM ET Company Participants Brianna Gerber - VP of Finance and IR Rob Fried - CEO Andrew Shao - SVP of Global Scientific and Regulatory Affairs Kevin Farr - CFO Conference Call Participants Jeffrey Cohen - Ladenburg Thalmann Mitchell Pinheiro - Sturdivant & Co. Jeff Van Sinderen - B. Riley Brian Nagel - Oppenheimer & Co. Sean McGowan - ROTH Capital Partners Disclaimer*: This transcript is designed to be used alongside the ...

| --- | --- | --- | |-------|--------------------------|-------| | | | | | | ChromaDex | | | | | | | | | | | | | | | | Earnings Conference Call | | | | | | | | Fourth Quarter 2021 | | Rob Fried Chief Executive Officer Kevin Farr Chief Financial Officer Andrew Shao SVP Scientific & Regulatory Affairs Nasdaq: CDXC | March 9, 2022 1 SAFE HARBOR STATEMENT This presentation and other written or oral statements made from time to time by representatives of ChromaDex contain "forwardlooking statements" within the m ...

ChromaDex Corporation (NASDAQ:CDXC) Q3 2021 Results Earnings Conference Call November 4, 2021 4:30 PM ET Company Participants Brianna Gerber - Vice President of Finance and Investor Relations Rob Fried - Chief Executive Officer Frank Jaksch Jr. - Co-Founder and Executive Chairman of the Board Kevin Farr - Chief Financial Officer Fadi Karam - Chief Marketing Officer Conference Call Participants Jeffrey Cohen - Ladenburg Thalmann Brian Nagel - Oppenheimer & Co. Mitchell Pinheiro - Sturdivant & Co., Inc. Ragh ...